Demand Analysis of U.S. Cancer Sample Prep Market
This analysis of the U.S. formalin fixed paraffin embedded (FFPE) sample prep market illuminates how the existing FFPE legacy in solid-tumor diagnostics is being transformed by advanced molecular techniques. Customer demand data collected by Frost & Sullivan provides the foundation for a market penetration model in which the relative growth stage of both the hospital and reference lab segments is determined. Furthermore, the adoption trend for FFPE sample prep automation is predicted by an install base forecast in clinical laboratories for 2011 to 2016. Companies that participate in the market include Qiagen, Life Technologies, and Roche Applied Sciences.
1. Executive Summary
2. U.S. Cancer Sample Prep Market